Skip to page content  Home  Recombinant DNA  Genetics, Health, and Society  Dual Use Research  Clinical Research Policy
  About RAC
  News and Events
  RAC Meetings
  Frequently Asked Questions
  Documents of Interest
  GeMCRIS
  NIH Guidelines
  Informed Consent
  IBC Information
  Educational Materials
 
Institutional Biosafety Committees
  Institutional Biosafety Committees (IBCs) are the cornerstone of institutional oversight of recombinant DNA research. The following information and resources are provided to help IBCs perform this critical role, as well as to inform others about the roles and responsibilities of these important committees.  
   Workshops, Safety Symposia and Policy Conferences  
   Key Definitions and Acronyms  
   Frequently Asked Questions  
   Educational Materials  
   Policy Guidance Documents  
   Investigator Responsibilities Under the NIH Guidelines for Research Involving Recombinant DNA Molecules  (June 22, 2009)  
   Tool for the Self-Assessment of the Institutional Biosafety Committee and Program of Oversight of Recombinant DNA Research (June 22, 2009)  
   Memorandum  describing how to use the self-assessment tool.  
   Self-assessment tool  
   -  Fillable PDF  (requires Adobe Acrobat 9.0 and higher to electronically save data)  
   -  Excel spreadsheet (with electronically fillable fields)  
   Major Actions under Section III-A of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules   (posted September 13, 2012; effective March 5, 2013)  
   NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules   (posted September 13, 2012; effective March 5, 2013)  
   Additional Guidance on the Content of Minutes of Institutional Biosafety Committee Meetings  (February 23, 2007)  
   Institutional Compliance Reminder  (December 6, 2004)  
   Guidance on Minutes of Institutional Biosafety Committee Meetings  (May 14, 2004)  
   Biosafety Guidance Documents  
   Biosafety Considerations for Research with Lentiviral Vectors  
   Biosafety Considerations when Cloning Full-Length cDNA of Certain RG4 RNA Viruses   
   Biosafety Considerations in Recombinant DNA Research with Pathogenic Viruses  
   Links of Interest to IBCs  
   Subscribe to OBA News  
  If you have questions about OBA's activities, interpretations of the NIH Guidelines, upcoming meetings, or related matters, do not hesitate to contact OBA staff by email at oba@od.nih.gov, or by phone at 301-496-9838.  
 
none
Disclaimer | Privacy Policy | FOIA | Accessibility | Directions to OBA
none
HHS - Home Page Department of Health and Human Services   National Institutes of Health - Home Page National Institutes of Health   N I H - Office of Science Policy Office of Science Policy   USA.gov - government made easy
none
N I H - Office of Biotechnology Activities N I H - Office of Science Policy National Institutes of Health, DHHS